Advanced in WT1-Related Wilms Tumor Syndromes

Dr. Benjamin Garmezy

Hematology | Oncology
Verdi Oncology Tennessee PC
2004 Hayes St, Suite 720, 
Nashville, TN 
Offers Telehealth

Advanced in WT1-Related Wilms Tumor Syndromes
Verdi Oncology Tennessee PC
2004 Hayes St, Suite 720, 
Nashville, TN 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Benjamin Garmezy is a Hematologist and an Oncologist in Nashville, Tennessee. Dr. Garmezy is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Renal Cell Carcinoma (RCC), Choriocarcinoma, Urothelial Cancer, and Adult Soft Tissue Sarcoma.

His clinical research consists of co-authoring 13 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology
Oncology
Licenses
Internal Medicine in TX
Hospital Affiliations
Tristar Horizon Medical Center
Tristar Centennial Medical Center
Williamson Medical Center
Tristar Summit Medical Center
Tristar Skyline Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Farm Bureau Health Plans
  • HMO
  • MEDICARE MAPD
  • MEDICARE PDP
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
US Health and Life
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

VERDI ONCOLOGY TENNESSEE PC
2004 Hayes St, Suite 720, Nashville, TN 37203
Call: 615-284-2310

Additional Areas of Focus

Dr. Garmezy has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Metastatic Uveal Melanoma

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


2 Clinical Trials

Dose Escalation and Expansion Clinical Study to Evaluate the Safety and Efficacy of ELU001 in Subjects Who Have Advanced, Recurrent or Refractory FRα Overexpressing Tumors
Dose Escalation and Expansion Clinical Study to Evaluate the Safety and Efficacy of ELU001 in Subjects Who Have Advanced, Recurrent or Refractory FRα Overexpressing Tumors
Enrollment Status: Terminated
Publish Date: August 07, 2024
Intervention Type: Drug
Study Drug: ELU001
Study Phase: Phase 1/Phase 2
A Phase 1, Open-Label Study of the Safety, Tolerability and Preliminary Clinical Activity of Allogeneic Invariant Natural Killer T (iNKT) Cells (agenT-797) as a Single Agent and in Combination With Approved Immune Checkpoint Inhibitors in Patients With Relapsed/ Refractory Solid Tumors
A Phase 1, Open-Label Study of the Safety, Tolerability and Preliminary Clinical Activity of Allogeneic Invariant Natural Killer T (iNKT) Cells (agenT-797) as a Single Agent and in Combination With Approved Immune Checkpoint Inhibitors in Patients With Relapsed/ Refractory Solid Tumors
Enrollment Status: Completed
Publish Date: April 24, 2024
Intervention Type: Drug
Study Phase: Phase 1
View 1 Less Clinical Trial

13 Total Publications

Developing biomarkers and methods of risk stratification: Consensus statements from the International Kidney Cancer Symposium North America 2024 Think Tank.
Developing biomarkers and methods of risk stratification: Consensus statements from the International Kidney Cancer Symposium North America 2024 Think Tank.
Journal: Urologic oncology
Published: May 12, 2025
View All 13 Publications
Similar Doctors
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Brian I. Rini
Hematology Oncology | Hematology | Oncology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Brian I. Rini
Hematology Oncology | Hematology | Oncology

Vanderbilt Health Clinicians, LLC

3601 The Vanderbilt Clinic, 
Nashville, TN 
 (0.9 miles away)
615-322-3000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Brian Rini is a Hematologist Oncology specialist and a Hematologist in Nashville, Tennessee. Dr. Rini is rated as an Elite provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Nephrectomy, and Prostatectomy. Dr. Rini is currently accepting new patients.

Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Kristin Ancell
Hematology | Oncology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Kristin Ancell
Hematology | Oncology

Vanderbilt Health Clinicians, LLC

3601 The Vanderbilt Clinic, 
Nashville, TN 
 (0.9 miles away)
615-322-3000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Kristin Ancell is a Hematologist and an Oncologist in Nashville, Tennessee. Dr. Ancell is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. Her top areas of expertise are Melanoma, Neuroendocrine Tumor, Clear Cell Sarcoma, WT1-Related Wilms Tumor Syndromes, and Gastrostomy.

Kathryn E. Beckermann
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Kathryn E. Beckermann
Hematology Oncology | Hematology | Oncology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Kathryn E. Beckermann
Hematology Oncology | Hematology | Oncology

Tennessee Oncology PLLC

4488 Carothers Pkwy, Suite 300, 
Franklin, TN 
 (16.2 miles away)
615-591-4764
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Kathryn Beckermann is a Hematologist Oncology specialist and a Hematologist in Franklin, Tennessee. Dr. Beckermann is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. Her top areas of expertise are Chromophobe Renal Cell Carcinoma, Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, and Adult Soft Tissue Sarcoma. Dr. Beckermann is currently accepting new patients.

VIEW MORE WT1-RELATED WILMS TUMOR SYNDROMES DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Garmezy's expertise for a condition
ConditionClose
      • Advanced
      • Adult Soft Tissue Sarcoma
        Dr. Garmezy is
        Advanced
        . Learn about Adult Soft Tissue Sarcoma.
        See more Adult Soft Tissue Sarcoma experts
      • Bladder Cancer
        Dr. Garmezy is
        Advanced
        . Learn about Bladder Cancer.
        See more Bladder Cancer experts
      • Cholangiocarcinoma (Bile Duct Cancer)
        Dr. Garmezy is
        Advanced
        . Learn about Cholangiocarcinoma (Bile Duct Cancer).
        See more Cholangiocarcinoma (Bile Duct Cancer) experts
      • Choriocarcinoma
        Dr. Garmezy is
        Advanced
        . Learn about Choriocarcinoma.
        See more Choriocarcinoma experts
      • Chromophobe Renal Cell Carcinoma
        Dr. Garmezy is
        Advanced
        . Learn about Chromophobe Renal Cell Carcinoma.
        See more Chromophobe Renal Cell Carcinoma experts
      • Clear Cell Sarcoma
        Dr. Garmezy is
        Advanced
        . Learn about Clear Cell Sarcoma.
        See more Clear Cell Sarcoma experts
      View All 18 Advanced Conditions
      • Experienced
      • Acute Myeloblastic Leukemia with Maturation
        Dr. Garmezy is
        Experienced
        . Learn about Acute Myeloblastic Leukemia with Maturation.
        See more Acute Myeloblastic Leukemia with Maturation experts
      • Acute Myeloblastic Leukemia without Maturation
        Dr. Garmezy is
        Experienced
        . Learn about Acute Myeloblastic Leukemia without Maturation.
        See more Acute Myeloblastic Leukemia without Maturation experts
      • Acute Myeloid Leukemia (AML)
        Dr. Garmezy is
        Experienced
        . Learn about Acute Myeloid Leukemia (AML).
        See more Acute Myeloid Leukemia (AML) experts
      • Adult Immune Thrombocytopenia
        Dr. Garmezy is
        Experienced
        . Learn about Adult Immune Thrombocytopenia.
        See more Adult Immune Thrombocytopenia experts
      • Agranulocytosis
        Dr. Garmezy is
        Experienced
        . Learn about Agranulocytosis.
        See more Agranulocytosis experts
      • Ampullary Cancer
        Dr. Garmezy is
        Experienced
        . Learn about Ampullary Cancer.
        See more Ampullary Cancer experts
      View All 63 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile
      For Patients
      • Our Story
      • How MediFind Works
      • Conditions A-Z
      • Doctor Directory
      • Symptoms Directory
      • Procedures Directory
      • Treatment Directory
      • Drug Directory
      • Infusion Center Finder
      • FAQ
      • Contact Us
      For Providers and Practices
      • Claim Your Profile
      • Newsroom
      Business Solutions
      • Provider
      • Network Solutions
      Additional Resources
      • Consumer Health Data Privacy Policy
      • Privacy Policy
      • Terms of Use
      • Advertising Policy
      • Content Policy
      Subscribe to our newsletter

      Sign up to stay informed about MediFind and get wellness sent your way.

      Close

        By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

        Bullet PinMediFind
        Follow us on
        This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
        © 2025 All Rights Reserved